CDRC’s respiratory resources support GP practices with the identification, assessment, review and ongoing management of patients with Asthma, COPD and inhaler optimisation..
Clinical Reports
Access
Until recently, CDRC’s EMIS Population Reports have been made available to access directly from the CDRC website. However, this has meant that there is no way of ensuring that they are being used appropriately and updated as necessary, representing a risk.
You can still access these reports directly from the CDRC team by emailing contact-cdrc@healthinnovationnenc.org.uk ; a member of the CDRC team will be able to provide access to the required reports and any ongoing support.
Guidance
Once imported into your EMIS system, the following report folder structure will be visible.
The CDRC Respiratory report folder contains multiple reports to support the identification, management and optimisation of treatment for respiratory conditions such as Asthma and COPD. These reports are separated into dedicated folders to improve navigation and usability.

Expand the 1. Respiratory Quality Improvement folder

The sub-folders are categorised into Asthma, COPD and Respiratory Medication Optmisation.
The Asthma folder contain reports to support identification of patients who may require review, action and/or management. For example the Inhaler Overuse and Safety report folder contains reports to identify patients who are potentially overusing their SABA Inhaler

The COPD folder contain report to support identification of your COPD patients who may require review, management, or optimisation of their treatment. Within this folder are reports for COPD Reconciliation to support the accuracy of your COPD register in light of the changes made to the COPD QoF Clusters.

Finally, the Respiratory Medication Optimisation folder contains reports to identify patient who may have poor concordance with their current treatment, or who may intervention with their current inhaler(s) or benefit from switching to a more environmentally friendly inhaler alternative.

